Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Colgate-Palmolive (CL)

NYSE: CL · Household Products · New York, NY

Our rating: Neutral

Neutral reaffirmed at $97.43, moderate conviction, November 2, 2026.

Breaks if: The Neutral call turns Cautious if revenue growth goes negative for two consecutive reported quarters — that would signal volume erosion beyond a pricing cycle and indicate structural shelf-share loss not visible in today's figures. It turns Positive if revenue growth re-accelerates to 4% or above for two consecutive quarters alongside an FCF margin that holds above 18% (currently running near 20.6%), confirming that pricing power and cost discipline are both intact and the franchise is compounding again. Neither condition is true at today's reported figures.

Key figures

Market value$78.5B
Revenue, last 12 months$21.3B
Net income, last 12 months$2.1B
Free cash flow, last 12 months$3.8B
Price to earnings38.2×
Free cash flow yield4.8%
Dividend yield2.1%
Operating margin14.8%
Return on equity358.9%
Beta to the S&P 500−0.01
Volatility, annualized21.3%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$5.4B4.6%$0.94$1.0B
June 30, 2026$5.4B4.9%$0.86$867M
March 31, 2026$5.3B8.4%$0.80$609M
December 31, 2025$5.2B5.8%$-0.04$1.3B
September 30, 2025$5.1B1.9%$0.91$1.1B
June 30, 2025$5.1B1.0%$0.91$776M
March 31, 2025$4.9B−3.0%$0.85$476M
December 31, 2024$4.9B−0.1%$0.90$1.1B

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

14 ledger entries and 26 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.